Pulmonary capillary hemangiomatosis-predominant vasculopathy in a patient with rheumatoid arthritis-associated interstitial lung disease: An autopsy report

Lippert, 1998, Pulmonary capillary hemangiomatosis: radiographic appearance, J. Thorac. Imag., 13, 49, 10.1097/00005382-199801000-00012 O'Keefe, 2015, Pulmonary capillary hemangiomatosis: a rare cause of pulmonary hypertension, Arch. Pathol. Lab Med., 139, 274, 10.5858/arpa.2013-0500-RS Galie, 2015, Eur. Respir. J., 46, 903, 10.1183/13993003.01032-2015 Odronic, 2015, Pulmonary capillary hemangiomatosis associated with connective tissue disease: a report of 4 cases and review of the literature, Ann. Diagn. Pathol., 19, 149, 10.1016/j.anndiagpath.2015.03.006 Montani, 2016, Pulmonary veno-occlusive disease, Eur. Respir. J., 47, 1518, 10.1183/13993003.00026-2016 Wagenvoort, 1978, Capillary haemangiomatosis of the lungs, Histopathology, 2, 401, 10.1111/j.1365-2559.1978.tb01734.x Guzman, 2019, Pulmonary capillary hemangiomatosis: a lesson learned, Autopsy & case reports, 9, e2019111, 10.4322/acr.2019.111 Lawler, 2005, Pulmonary capillary hemangiomatosis: multidetector row CT findings and clinico-pathologic correlation, J. Thorac. Imag., 20, 61, 10.1097/01.rti.0000139390.26138.94 Fernandez-Alonso, 1999, Pulmonary capillary hemangiomatosis as cause of pulmonary hypertension in a young woman with systemic lupus erythematosus, J. Rheumatol., 26, 231 Yeo, 2019, A case of early diagnosis of pulmonary capillary hemangiomatosis in a worker with exposure to silica, BMC Pulm. Med., 19, 133, 10.1186/s12890-019-0896-5 Sakashita, 2011, A case of pulmonary capillary hemangiomatosis with pulmonary fibrosis associated with MMP-9 related pulmonary remodeling, Pathol. Int., 61, 306, 10.1111/j.1440-1827.2011.02652.x Sato, 2013, Broad and heterogeneous vasculopathy in pulmonary fibrosis and emphysema with pulmonary hypertension, Respirology case reports, 1, 10, 10.1002/rcr2.7 Authors/Task Force, 2016, Eur. Heart J., 37, 67, 10.1093/eurheartj/ehv317 Fukuda, 2019, Guidelines for the treatment of pulmonary hypertension (JCS 2017/JPCPHS 2017), Circ. J. : official journal of the Japanese Circulation Society, 83, 842, 10.1253/circj.CJ-66-0158 Humbert, 1998, Pulmonary edema complicating continuous intravenous prostacyclin in pulmonary capillary hemangiomatosis, Am. J. Respir. Crit. Care Med., 157, 1681, 10.1164/ajrccm.157.5.9708065 Palmer, 1998, Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease, Chest, 113, 237, 10.1378/chest.113.1.237 Ogawa, 2012, Safety and efficacy of epoprostenol therapy in pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis, Circ. J. : official journal of the Japanese Circulation Society, 76, 1729, 10.1253/circj.CJ-11-0973 Tanabe, 2015, Multi-institutional retrospective cohort study of patients with severe pulmonary hypertension associated with respiratory diseases, Respirology, 20, 805, 10.1111/resp.12530 Igarashi, 2013, Four cases with group 3 out-of-proportion pulmonary hypertension with a favorable response to vasodilators, Respir Med Case Rep, 9, 4 Sato, 2016, The effects of pulmonary vasodilating agents on right ventricular parameters in severe group 3 pulmonary hypertension: a pilot study, Pulm. Circ., 6, 524, 10.1086/688712 Pulido, 2013, Macitentan and morbidity and mortality in pulmonary arterial hypertension, N. Engl. J. Med., 369, 809, 10.1056/NEJMoa1213917 Frazier, 2007, vol. 27, 867 Anazawa, 2019, Features of radiological and physiological findings in pulmonary capillary hemangiomatosis: an updated pooled analysis of confirmed diagnostic cases, Pulm. Circ., 9, 10.1177/2045894019896696 Miura, 2013, Different sizes of centrilobular ground-glass opacities in chest high-resolution computed tomography of patients with pulmonary veno-occlusive disease and patients with pulmonary capillary hemangiomatosis, Cardiovasc. Pathol. : the official journal of the Society for Cardiovascular Pathology, 22, 287, 10.1016/j.carpath.2012.12.002